Contents

Current Drug Targets, Volume 7 - Number 10

Editorial [Hot Topic: Targeting Arterial Thrombosis - Current Concepts and Future Developments (Guest Editor: Florian Krotz)]

, 7(10): 1231

Florian Krotz


DOI: 10.2174/138945006778559201




Redox Modification of Platelet Glycoproteins

, 7(10): 1233 - 1241

D. W. Essex and M. Li


DOI: 10.2174/138945006778559193




The Many Antithrombotic Actions of Nitric Oxide

, 7(10): 1243 - 1251

Constantine Tziros and Jane E. Freedman


DOI: 10.2174/138945006778559111




G-protein Dependent Platelet Signaling - Perspectives for Therapy

, 7(10): 1253 - 1263

H. Shankar, B. Kahner and S. P. Kunapuli


DOI: 10.2174/138945006778559166




Phosphotyrosine Signaling in Platelets: Lessons for Vascular Thrombosis

, 7(10): 1265 - 1273

Janet L. K. Wee and Denise E. Jackson


DOI: 10.2174/138945006778559265




Cyclooxygenase Inhibition and Atherothrombosis

, 7(10): 1275 - 1284

Hae-Young Sohn and Florian Krotz


DOI: 10.2174/138945006778559102




Thrombin Inhibitors and Anti-Factor Xa Agents in the Treatment of Arterial Occlusion

, 7(10): 1285 - 1290

V. Klauss and M. Spannagl


DOI: 10.2174/138945006778559148




Editorial [Hot Topic: Beyond Chemotherapy: Future Directions in Lymphoma Treatment (Guest Editor: Thomas Decker)]

, 7(10): 1291

Thomas Decker


DOI: 10.2174/138945006778559238




Radioimmunotherapy of Non-Hodgkins Lymphomas

, 7(10): 1293 - 1300

Bruce D. Cheson


DOI: 10.2174/138945006778559157




Immunotoxins in the Treatment of Hematologic Malignancies

, 7(10): 1301 - 1311

Robert J. Kreitman and Ira Pastan


DOI: 10.2174/138945006778559139




Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia

, 7(10): 1313 - 1327

Dirk Winkler, Hartmut Dohner and Stephan Stilgenbauer


DOI: 10.2174/138945006778559184




Targeting the Oncogenic Tyrosine Kinase NPM-ALK in Lymphoma: The Role of Murine Models in Defining Pathogenesis and Treatment Options

, 7(10): 1329 - 1334

Cornelius Miething, Christian Peschel and Justus Duyster


DOI: 10.2174/138945006778559229




The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma

, 7(10): 1335 - 1340

P. Jost, C. Peschel and J. Ruland


DOI: 10.2174/138945006778559256




Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies

, 7(10): 1341 - 1347

Constantine S. Mitsiades, Nicholas Mitsiades, Teru Hideshima, Paul G. Richardson and Kenneth C. Anderson


DOI: 10.2174/138945006778559247




Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery

, 7(10): 1349 - 1359

Ingo Ringshausen, Christian Peschel and Thomas Decker


DOI: 10.2174/138945006778559210




Therapeutic Targeting of Apoptotic Pathways in Cancer

, 7(10): 1361 - 1369

Johannes Meiler and Martin Schuler


DOI: 10.2174/138945006778559175




Current status of Immunotherapy in B Cell Malignancies

, 7(10): 1371 - 1374

D. M. Kofler, C. Mayr and C.-M. Wendtner


DOI: 10.2174/138945006778559120




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science